Lake Bleu Capital is a China-focused venture capital firm investing in healthcare and life sciences companies, including biotechnology, pharmaceuticals, medical devices and oncology. It participates in later-stage venture financings and has acted as a lead or co-lead investor in Chinese healthcare rounds, making it most relevant for founders raising growth-oriented capital in China’s life sciences ecosystem.